Archimedes, LLC – Trademark Portfolio
Entity Type: 16
Archimedes, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include QALYIQ, ARCHIMEDES, and SPECIALTYIQ. The owner is based in Brentwood, TN.
278 Franklin Rd
Brentwood, TN 37027
Showing of trademarks Trademarks
Trademark Classifications
Archimedes, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Archimedes, LLC have?
Archimedes, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Archimedes, LLC file in?
Archimedes, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 18 (Leather Goods). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Archimedes, LLC's most well-known trademarks?
Archimedes, LLC's registered trademark portfolio includes well-known marks such as QALYIQ, ARCHIMEDES, and SPECIALTYIQ. These are among 3 currently registered trademarks in the portfolio.
What is Archimedes, LLC's trademark registration success rate?
Archimedes, LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.